<p>神經分泌生物科學宣佈發佈專家建議，關於在啓動 CRENESSITY® (crinecerfont) 治療經典先天性腎上腺增生後減少糖皮質激素劑量的指導 | NBIX 股票新聞</p>

神經分泌生物科學

<p>神經分泌生物科學宣佈發佈專家建議，關於在啓動 CRENESSITY®（crinecerfont）治療經典先天性腎上腺增生後減少糖皮質激素劑量的指導 | NBIX 股票新聞</p>

<p>Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia | NBIX Stock News</p>
<div class="lb-trans"><p>神經分泌生物科學宣佈發佈專家建議，關於在啓動 CRENESSITY® (crinecerfont) 治療經典先天性腎上腺增生後減少糖皮質激素劑量的指導 | NBIX 股票新聞</p>
</div>

Neurocrine Biosciences Announces Publication of Expert Recommendations for Glucocorticoid Dose Reduction after Initiating CRENESSITY® (crinecerfont) for the Treatment of Classic Congenital Adrenal Hyperplasia | NBIX Stock News

神經分泌生物科學宣佈在啓動 CRENESSITY®（crinecerfont）用於治療經典型先天性腎上腺增生症後，發表了關於糖皮質激素劑量減少的專家建議 | NBIX 股票新聞